Horn, K. P., Yap, J. T., Agarwal, N., Morton, K. A., Kadrmas, D. J., Beardmore, B., . . . Hoffman, J. M. (2015). FDG and FLT-PET for Early measurement of response to 37.5 mg daily sunitinib therapy in metastatic renal cell carcinoma. Cancer Imaging.

Horn, Kevin P., Jeffrey T. Yap, Neeraj Agarwal, Kathryn A. Morton, Dan J. Kadrmas, Britney Beardmore, Regan I. Butterfield, Kenneth Boucher, und John M. Hoffman. "FDG and FLT-PET for Early Measurement of Response to 37.5 Mg Daily Sunitinib Therapy in Metastatic Renal Cell Carcinoma." Cancer Imaging 2015.

Horn, Kevin P., et al. "FDG and FLT-PET for Early Measurement of Response to 37.5 Mg Daily Sunitinib Therapy in Metastatic Renal Cell Carcinoma." Cancer Imaging 2015.